Which closed-end funds own Sagimet Biosciences Inc?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $9.3M. Security type: common equity. Country: United States. CUSIP 786700104 · ISIN US7867001049 · ticker SGMT.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.95% | $6.6M | 847,700 sh | $690M | 3.5% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.22% | $2.3M | 301,060 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.07% | $405K | 52,449 sh | $573M | 3.7% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “SGMT” → · Compare two funds’ portfolios →